Literature DB >> 23895299

Genetic investigation into ethnic disparity in polycystic ovarian syndrome.

Shuxia Li1, Dongyi Zhu, Hongmei Duan, Qihua Tan.   

Abstract

Polycystic ovarian syndrome is universally the most common endocrinopathy in women of reproductive age. It is characterized by composite clinical phenotypes reflecting the reproductive impact of ovarian dysfunction (androgen excess, oligo-/anovulation, polycystic ovary) and metabolic abnormalities (insulin resistance, obesity) with widely varying symptoms among the affected. Studies have shown a clear pattern of disparity in clinical manifestations of its component phenotypes across ethnic populations. Recent genetic association studies suggested differential genetic background that could contribute to the observed ethnic disparity. We summarize the current status in genetic studies of the disorder in different populations with a focus on ethnicity. Especially, we highlight and discuss the applications of recent developments in DNA sequencing, global transcriptional and epigenetic profiling that could help to unravel the molecular basis of the interethnic difference in the pathogenesis of the syndrome. It is hoped that identification and characterization of population-specific structural genetic and functional genomic patterns could help to not only deepen our understanding of the aetiology but also develop more efficient strategies for treatment and prevention of polycystic ovarian syndrome.

Entities:  

Mesh:

Year:  2013        PMID: 23895299     DOI: 10.3109/09513590.2013.819081

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  4 in total

1.  Protective effects of lidocaine on polycystic ovary syndrome through modulating ovarian granulosa cell physiology via PI3K/AKT/mTOR pathway.

Authors:  Haixia Xiong; Qiong Hu; Qun Jiang
Journal:  Cytotechnology       Date:  2022-02-24       Impact factor: 2.058

2.  Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity.

Authors:  Kehinde S Olaniyi; Stephanie E Areloegbe; Mosunmola B Oyeleke
Journal:  Endocrine       Date:  2022-09-16       Impact factor: 3.925

3.  Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.

Authors:  Lan Li; Ji Eun Ryoo; Kyung-Ju Lee; Bum-Chae Choi; Kwang-Hyun Baek
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

Review 4.  Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity.

Authors:  Wendy M Wolf; Rachel A Wattick; Olivia N Kinkade; Melissa D Olfert
Journal:  Int J Environ Res Public Health       Date:  2018-11-20       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.